Article Sidebar

Submitted
Apr 15, 2021
Published
Apr 15, 2021
Download
PDF
Statistic
Read Counter : 75 Download : 35

Main Article Content

Abstract

The aim of the present work was to develop and optimize gastroretentive floating system of cefixime (CF) for the effective treatment. The present study was carried out with an objective of preparation and in vivo evaluation of floating tablets of using cefixime as a model drug using Eudragit polymers (Eudragit-S100, Eudragit-RLPO &Eudragit-RSPO) to improve oral bioavailability of cefixime floating tablets by increasing gastric residence time. The tablets were prepared by direct compression method. The effect of polymers concentration and viscosity grades of Eudragit on drug release profile was evaluated. The result of in vitro dissolution study showed that the drug release profile could be controlled by increasing the concentration of Eudragit-RLPO. The optimized formulation (F18) containing Eudragit-RLPOshowed 99.24% drug release at the end of 24h. Changing the viscosity grade of Eudragit-RLPO had no significant effect on drug release profile. The optimized formulations (F18) containing sodium bicarbonate 40mg per tablet showed desired buoyancy (floating lag time of about 20 min and total floating time of >24hr). Optimized formulation (F18) followed diffusion controlled zero order kinetics and fickian transport of the drug. FTIR and DSC studies revealed the absence of any chemical interaction between drug and polymers used. The best formulation (F18) was selected based on in vitro characteristics and was used in vivo radiographic studies by incorporating BaSO4. These studies revealed that the tablets remained in the stomach for 24hrs in fasting human volunteers and indicated that gastric retention time was increased by the floating principle, which was considered desirable for the absorption window drugs. Studies to evaluate the pharmacokinetics in vivo showed better bioavailability, area under the concentration time curve, elimination rate constant and half-life than marketed product.

Keywords

Cefixime Eudragit-S100 Eudragit-RLPO Eudragit-RSPO Sodium alginate PVP K30 Magnesium stearate and micro crystalline cellulose Radiographic studies

Article Details

How to Cite
E. Sathish Reddy, Meesala. SrinivasaRao, & Mohammed Ibrahim. (2021). Formulation and in vitro, in vivo evaluation of Cefiximecontrolled Gastroretentive floating drug delivery system. International Journal of Research in Pharmacology & Pharmacotherapeutics, 6(2), 134-146. https://doi.org/10.61096/ijrpp.v6.iss2.2017.134-146
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Moes J. Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst, 10, 1993, 143‐59.
  2. [2]. Deshpande A, Shah N, Rhodes C, Malick W. Development of a novel controlled release system for gastric retention. Pharm Res., 14, 1997, 815‐9.
  3. [3]. Tripathi KD. Essentials of medical pharmacology. New delhi: jaypee brothers medical publishers (p) LTD, 6, 2008, 254.
  4. [4]. www.Drug Bank (CefpodoximeProxitel).
  5. [5]. Tadros M. Eur J of Pharma and Biopharma. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: Development, optimization and in vitroin vivo evaluation in healthy human volunteers. 74, 2010, 332–339.
  6. [6]. Higuchi T, Mechanism of sustained action medication theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 50, 1961, 874-875.
  7. [7]. Siepmann J, Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Delivery Reviews. 48, 2001, 139-157.
  8. [8]. Garg R, Gupta GD. Progress in Controlled Gastroretentive Delivery Systems. Trop J of Pharm Res. 7(3), 2008, 1055-1066.
  9. [9]. Anand Patel. Development and In Vivo Floating Behavior of Verapamil HClIntragastric Floating Tablets. AAPSPharmSciTech. 10(1), 2009, 310-315.
  10. [10]. PrasannaKumari J, Ramarao T, Jayaveera K N, Bhikshapathi D V R N, MadhusudanRao Y. Design and In vivo evaluation of Metoprolol Tartrate bilayer floating tablets in healthy human volunteers. Int J of Drug Delivery. 6, 2014, 14-23.
  11. [11]. Kiran B. V, SreenivasRao B, Somshankar D. Validation of drugs in Pharmaceutical Dosage by Reverse-Phase HPLC with Internal Standard Method, J of Chemistry. 2013; Article ID 578537.